nach oben

Archives of Virology

Erschienen in:

27.10.2017 | Brief Report

An influenza A virus vaccine based on an M2e-modified alphavirus

verfasst von: Haritha Ramya Krishnavajhala, Jacqueline Williams, Hans Heidner

Erschienen in: Archives of Virology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

The 23-residue external domain of the influenza A virus M2 protein (M2e) has significant potential as a vaccine antigen. Here, we describe the construction and characterization of an M2e-modified Sindbis virus designated E2S1-M2e. E2S1-M2e virions contain M2e as an N-terminal extension of the E2 glycoprotein and therefore express 240 copies of the M2e peptide on their surface. The E2S1-M2e virus expressed M2e in an accessible and immunogenic form and induced M2e-specific antibodies when administered to mice. Mice that received an intranasal vaccination with E2S1-M2e were protected against a lethal challenge with a virulent, mouse-adapted strain of influenza A virus.

Boehme KW, Williams JC, Johnston RE, Heidner HW (2000) Linkage of an alphavirus host range restriction to the carbohydrate-processing phenotypes of the host cell. J Gen Virol 81:161–170CrossRefPubMed

Feng JQ, Zhang M, Mozdzanowska K, Zharikova D, Hoff H, Wunner W, Couch RB, Gerhard W (2006) Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol J 3:1–13CrossRef

Heidner HW, Johnston RE (1994) The amino-terminal residue of Sindbis virus glycoprotein E2 influences virus maturation, specific infectivity for BHK cells, and virulence in mice. J Virol 68:8064–8070PubMedPubMedCentral

Heidner HW, McKnight KL, Davis NL, Johnston RE (1994) Lethality of PE2 incorporation into Sindbis virus can be suppressed by second-site mutations in E3 and E2. J Virol 68:2683–2692PubMedPubMedCentral

Helenius A (1992) Unpacking the incoming influenza virus. Cell 69:577–578CrossRefPubMed

Holsinger LJ, Lamb RA (1991) Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology 183:32–43CrossRefPubMed

Ito T, Gorman OT, Kawaoka Y, Bean WJ, Webster RG (1991) Evolutionary analysis of the influenza A virus M gene with comparisons of the M1 and M2 proteins. J Virol 65:5491–5498PubMedPubMedCentral

Klimstra WB, Williams JC, Ryman KD, Heidner HW (2005) Targeting Sindbis virus-based vectors to Fc receptor-positive cell types. Virology 338:9–21CrossRefPubMed

Kolpe A, Schepens B, Fiers W, Saelens X (2016) M2-based influenza vaccines: recent advances and clinical potential. Expert Rev Vaccines 16:123–136CrossRefPubMed

10.

Krammer F, Palese P (2015) Advances in the development of influenza virus vaccines. Nat Rev 14:167–182

11.

Lamb RA, Zebedee SL, Richardson CD (1985) Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell 40:627–633CrossRefPubMed

12.

London SD, Schmaljohn AL, Dalrymple JM, Rice CM (1992) Infectious enveloped RNA virus antigenic chimeras. Proc Natl Acad Sci USA 89:207–211CrossRefPubMedPubMedCentral

13.

Luytjes W, Enouf V, Schipper M, Gijzen K, Liu WM, van der Lubben M, Meijer A, van der Werf S, Soethout EC (2012) HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains. Vaccine 30:5262–5269CrossRefPubMed

14.

Mukhopadhyay S, Zhang W, Gabler S, Chipman PR, Strauss EG, Strauss JH, Baker TS, Kuhn RJ, Rossmann MG (2006) Mapping the structure and function of the E1 and E2 glycoproteins in alphaviruses. Structure 14:63–73CrossRefPubMedPubMedCentral

15.

Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W (1999) A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 5:1157–1163CrossRefPubMed

16.

Palese P (2006) Making better influenza virus vaccines. Emerg Infect Dis 12:61–65CrossRefPubMedPubMedCentral

17.

Paredes AM, Brown DT, Rothnagel R, Chiu W, Schoepp RJ, Johnston RE (1993) Three-dimensional structure of a membrane-containing virus. Proc Natl Acad Sci USA 90:9095–9099CrossRefPubMedPubMedCentral

18.

Paredes AM, Heidner H, Thuman-Commike P, Prasad BVV, Johnston RE, Chiu W (1998) Structural localization of the E3 glycoprotein in attenuated Sindbis virus mutants. J Virol 72:1534–1541PubMedPubMedCentral

19.

Pinto LH, Holsinger LJ, Lamb RA (1992) Influenza virus M2 protein has ion channel activity. Cell 69:517–528CrossRefPubMed

20.

Reid AH, Fanning TG, Janczewski TA, McCall S, Taubenberger JK (2002) Characterization of the 1918 “Spanish” influenza virus matrix gene segment. J Virol 76:10717–10723CrossRefPubMedPubMedCentral

21.

Rice CM, Strauss JH (1982) Association of Sindbis virion glycoproteins and their precursors. J Mol Biol 154:325–348CrossRefPubMed

22.

Ryman KD, Klimstsra WB, Nguyen KB, Biron CA, Johnston RE (2000) Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol 74:3366–3378CrossRefPubMedPubMedCentral

23.

Sakaguchi T, Leser GP, Lamb RA (1996) The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J Cell Biol 133:733–747CrossRefPubMed

24.

Schmaljohn AL, Johnson ED, Dalrymple JM, Cole GA (1982) Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature 297:70–72CrossRefPubMed

25.

Schnell JR, Chou JJ (2008) Structure and mechanism of the M2 proton channel of influenza A virus. Nature 451:591–595CrossRefPubMedPubMedCentral

26.

Stouffer AL, Acharya R, Salom D, Levine AS, DiCostanzo L, Soto CS, Tereshko V, Nanda V, Stayrook S, DeGrado WF (2008) Structural basis for the function and inhibition of an influenza virus proton channel. Nature 451:596–599CrossRefPubMed

27.

Sugrue RJ, Hay AJ (1991) Structural characteristics of the M2 protein of influenza A virus: evidence that it forms a tetrameric channel. Virology 180:617–624CrossRefPubMed

28.

Takeuchi K, Lamb RA (1994) Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plaque virus hemagglutinin during intracellular transport. J Virol 68:911–919PubMedPubMedCentral

29.

Tong S, Li Y, Rivailler P, Conrardy C, Castillo DA, Chen LM, Recuenco S, Ellison JA et al (2012) A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci USA 109:4269–4274CrossRefPubMedPubMedCentral

30.

Von Bonsdorff CH, Harrison SC (1975) Sindbis virus glycoproteins form a regular icosahedral lattice. J Virol 16:141–145

31.

Whetter LE, MacLachlan NJ, Gebhard DH, Heidner HW, Moore PF (1989) Bluetongue virus infection of bovine monocytes. J Gen Virol 70:1663–1676CrossRefPubMed

32.

Zebedee SL, Lamb RA (1988) Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol 62:2762–2772PubMedPubMedCentral

Titel: An influenza A virus vaccine based on an M2e-modified alphavirus
verfasst von: Haritha Ramya Krishnavajhala
Jacqueline Williams
Hans Heidner
Publikationsdatum: 27.10.2017
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 2/2018
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-017-3578-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

An influenza A virus vaccine based on an M2e-modified alphavirus

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

Update Innere Medizin

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Prevalence and genomic characteristics of canine kobuvirus in southwest China

PB2 and HA mutations increase the virulence of highly pathogenic H5N5 clade 2.3.4.4 avian influenza virus in mice

Early HIV infection among persons referred for malaria parasite testing in Nigeria

Feline immudeficiency virus subtypes B and A in cats from São Luis, Maranhão, Brazil

Epidemiology of hepatitis B in pregnant Iranian women: a systematic review and meta-analysis

Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

Update Innere Medizin